Document is current
Any future updates will be listed below
-
Authors
Reyes, Lauren
Naser, Lena
Weiner, Warren S.
Thifault, Darren https://orcid.org/0000-0001-9710-1307
Stahl, Erik
McCreary, Liam https://orcid.org/0009-0002-3011-8475
Nott, Rohini
Quick, Colton
Buchberger, Alex
Alvarado, Carlos
Rivera, Andrew
Miller, Joseph A.
Khatiwala, Ruchi
Cherry, Brian R.
Nelson, Ronald https://orcid.org/0000-0003-4245-0432
Martin-Garcia, Jose M.
Stephanopoulos, Nicholas https://orcid.org/0000-0001-7859-410X
Fromme, Raimund https://orcid.org/0000-0003-4835-1080
Fromme, Petra https://orcid.org/0000-0003-0953-4909
Cance, William
Marlowe, Timothy https://orcid.org/0000-0002-9383-9803
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R41CA240124, R37CA065910, P30CA023074, R42CA240124)
- License Information
-
More Information
Article History
Received: 10 March 2023
Accepted: 13 February 2025
First Online: 28 February 2025
Competing interests
: Timothy Marlowe, Ph.D. is Chief Scientific Officer and has an equity interest in FAKnostics LLC, which has been disclosed to the University of Arizona. William Cance, M.D. has a family member with an equity interest in FAKnostics LLC. Conflicts of interest resulting from this interest are being managed by The University of Arizona in accordance with its conflict-of-interest policies. The remaining authors declare no competing interests.
